You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Ravgen, Inc. v. Illumina, Inc. (D. Del. 2020)

✉ Email this page to a colleague

« Back to Dashboard

Ravgen, Inc. v. Illumina, Inc. (D. Del. 2020)

Docket	⤷ Sign Up	Date Filed	2020-12-03
Court	District Court, D. Delaware	Date Terminated	2023-04-14
Cause	35:1 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Plaintiff	Referred To	Jennifer L. Hall
Parties	ILLUMINA, INC.; VERINATA HEALTH, INC.
Patents	10,482,993; 7,727,720
Attorneys	Joze Welsh; Jun Tong
Firms	Farnan LLP
Link to Docket	External link to docket

Biologic Drugs cited in Ravgen, Inc. v. Illumina, Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Ravgen, Inc. v. Illumina, Inc. (D. Del. 2020)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-12-03	1	Complaint	,155,984; 10,388,403; 10,415,089; 10,435,751; 10,482,993; 10,586,610; 10,591,391; 10,612,096; 10,658,… 10,388,403; 10,415,089; 10,435,751; 10,482,993; 10,586,610; 10,591,391; 10,612,096; 10,658,…United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application	External link to document
2023-04-14	106	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2; US 7,332,277 …2020 14 April 2023 1:20-cv-01644 830 Patent Plaintiff District Court, D. Delaware	External link to document
2021-02-16	11	Answer to Counterclaim	infringed at least 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”). Ravgen further …(Declaration of Non-Infringement of U.S. Patent No. 7,727,720) 7. Ravgen incorporates by… (Declaration of Invalidity of U.S. Patent No. 7,727,720) 15. Ravgen incorporates by…infringed either the ’720 Patent or the ’277 Patent arising under the Patent Laws of the United States…it is the legal owner by assignment of the ’720 patent. 10. Ravgen admits that it has alleged	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.